Brief: Cipher Pharmaceuticals Q3 earnings per basic share from continuing operations $0.15

Cipher Pharmaceuticals

03/11/2017 10:00

Nov 3 (Reuters) - Cipher Pharmaceuticals Inc  CPH.TO  
    * Cipher Pharmaceuticals reports Q3 2017 operating & 
financial 
results 
    * Cipher Pharmaceuticals Inc - qtrly total net revenue 
increased 
29% to $10.1 million, from $7.8 million in Q3 2016 
    * Cipher Pharma - on Nov 2,  Galephar confirmed resumption 
of 
production at both Juncos, Humacao manufacturing facilities 
    * Cipher Pharma  - does not anticipate any impact to 
product 
supply resulting from interruption of manufacturing at 
Galephar's facilities in Puerto Rico 
    * Cipher Pharmaceuticals Inc - qtrly income from continuing 
operations of $3.9 million, or $0.15 per basic share 
    * Q3 revenue view $9.2 million -- Thomson Reuters I/B/E/S 
 
Source text for Eikon:  ID:nCNW3Jr5ya  
Further company coverage:  CPH.TO  
 
 ((Bangalore.newsroom@thomsonreuters.com;))